Clinical trial
RUSSE / Russian Spiriva® Safety & Efficacy Study
NCT00613574 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RUSSE / Russian Spiriva® Safety & Efficacy Study
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- October 31, 2007
- Enrollment
- 407 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
copd